For investors aiming to benefit from increasing corporate momentum, a mixed technical and fundamental method can be an effective plan. The process involves finding companies showing solid basic business growth, shown by strong sales and earnings increases, while also displaying financial soundness and profit to maintain that growth. This basic strength forms the base. The plan then adds technical study, searching for stocks whose price movement is moving beyond set forms, indicating market acceptance of the basic story and the chance for a continued rise. This combination of sound basics and positive technical momentum seeks to find chances where a company's getting better outlooks are starting to be seen in its stock price.
Cardinal Health Inc (NYSE:CAH) offers a clear example of this plan at work. As a leading distributor of pharmaceuticals and medical products, the company works at the center of the healthcare supply chain. The latest basic and technical information indicates it is performing well in this vital part, attracting the attention of both growth and momentum investors.
Basic Growth Foundation
The center of the growth investment idea for Cardinal Health depends on its quickening financial results. The company's basic report shows a Growth Rating of 7/10, pointing to firm and getting better business measures. This score is key for the plan, as lasting price gains are usually driven by growing earnings and income.
Important growth points from the report are:
- Earnings Per Share (EPS) Growth: EPS rose by 24.32% over the last year, with a good 3-year average growth of 8.62%. More notably, analysts think this quickening will persist, with future EPS growth forecast at 14.46% each year.
- Income Momentum: Income grew by 10.13% in the last year, and future growth is predicted at 9.66% per year. The report states that this income growth rate is quickening.
- Profit and Soundness: While not very high, the company's Profit and Financial Soundness ratings both are at 5/10. This is notable because it shows a level of steadiness. The company is producing a firm Return on Invested Capital (14.50%, doing better than 91% of its industry group) and keeps a workable debt level compared to its cash flow, which supports ongoing growth spending without too much financial danger.
You can examine the full details of Cardinal Health's financial positives and negatives in its specific basic study report.
Technical Move Beyond Pattern
Sound basics are only one part; the market's response is what finally moves price. Cardinal Health's technical view strongly supports the basic story. The stock gets a high-level Technical Rating of 10/10 and a Setup Rating of 8/10, showing very good price momentum and a positive chart form.
The technical report lists several positive elements:
- Positive Direction Agreement: Both the long-term and short-term directions are positive, a standard sign of continued buying interest across different time frames.
- Firm Relative Results: The stock has done better than 90% of the market over the past year and 88% of its group in the Health Care Providers & Services field, showing field strength.
- Move Beyond Setup: The report states the stock is trading near its 52-week high and has lately been holding in a zone. It finds a clear resistance point just above the present price. A clear move past this point would confirm a technical move beyond, suggesting the holding time has finished and a new step upward may be starting. The setup is said to have "very little resistance above the current price," which might permit a notable move if the move beyond happens.
For a close look at the support, resistance, and trade setup, see the full technical study report.
Price and Points
From a price view, Cardinal Health seems fairly valued within its growth setting. Its P/E ratio is about equal to the wider S&P 500 but is less expensive than almost 66% of its industry group. When growth is included through the PEG ratio, the price is seen as fitting. This balance is important for the plan; a very overpriced stock, even with strong growth and momentum, may have little room to rise.
Investors should note, however, the company's low profit margins, a trait of the distribution business, and its somewhat weak liquidity ratios (Current and Quick Ratio), which the basic report marks as points of watch. These elements highlight the importance of the company's operational effectiveness in a high-volume, low-margin field.
Summary
Cardinal Health Inc shows the search for stocks where basic gain meets positive technical momentum. Its quickening earnings and sales growth give a firm business reason, while its high-level technical rating and possible move beyond pattern indicate the market is actively valuing these results. The plan aims to find such matches early, setting up for a direction that is basically supported and technically affirmed.
This study of CAH was found using a set screen that sorts for strong growth stocks with positive technical setups. If you want to find other companies that fit similar conditions, you can view the results of this screen here.
Disclaimer: This article is for information and learning only and does not form investment guidance, a suggestion, or a deal to buy or sell any security. The study is based on data and reports given by other parties. Investors should do their own separate study and think about their personal money situation and risk comfort before making any investment choices. Past results are not a guide for future results.